Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5289837
Max Phase: Preclinical
Molecular Formula: C48H78O23
Molecular Weight: 1023.13
Associated Items:
ID: ALA5289837
Max Phase: Preclinical
Molecular Formula: C48H78O23
Molecular Weight: 1023.13
Associated Items:
Canonical SMILES: CCCCCCCCO[C@@H]1O[C@@H](C)[C@H](OC(=O)CCCCC)[C@@H](O[C@@H]2O[C@@H](C)[C@H](OC(C)=O)[C@@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@H](O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4OC(C)=O)[C@H]3OC(C)=O)[C@H]2OC(C)=O)[C@H]1O
Standard InChI: InChI=1S/C48H78O23/c1-12-14-16-17-18-20-22-58-45-35(57)39(36(24(4)60-45)68-32(54)21-19-15-13-2)69-47-43(66-30(10)52)42(38(25(5)61-47)64-28(8)50)71-48-44(67-31(11)53)41(37(26(6)62-48)63-27(7)49)70-46-40(65-29(9)51)34(56)33(55)23(3)59-46/h23-26,33-48,55-57H,12-22H2,1-11H3/t23-,24-,25-,26-,33-,34+,35+,36-,37-,38-,39-,40+,41+,42+,43+,44+,45+,46-,47-,48-/m0/s1
Standard InChI Key: IOZDPMUCIIZTGL-IEOAANPOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1023.13 | Molecular Weight (Monoisotopic): 1022.4934 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Govindarajan M.. (2018) Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics., 143 [PMID:29126728] [10.1016/j.ejmech.2017.10.015] |
Source(1):